Abilify as an Adjunctive Treatment for Refractory Depression.

This study has been completed.
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by:
St. Luke's-Roosevelt Hospital Center
ClinicalTrials.gov Identifier:
NCT00220636
First received: September 21, 2005
Last updated: June 5, 2007
Last verified: June 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given